• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人工静脉瓣膜的研发。

Development of a prosthetic venous valve.

作者信息

Hill R, Schmidt S, Evancho M, Hunter T, Hillegass D, Sharp W

出版信息

J Biomed Mater Res. 1985 Sep;19(7):827-32. doi: 10.1002/jbm.820190708.

DOI:10.1002/jbm.820190708
PMID:4077898
Abstract

The pathology of thrombophlebitis primarily results from the obliteration of venous valves in the lower extremities. The objective of this study was to develop a prosthetic venous valve that could be implanted in the human femoral system to ameliorate the deleterious effects of thrombophlebitis. Prosthetic venous valves were produced from two materials: Pellethane valves were fabricated from a dip-casting process; umbilical vein valves were produced by a fixation process. The valves were evaluated as implants within the external jugular veins of 10 research dogs. Each animal was implanted with one Pellethane valve in one external jugular vein and one umbilical vein venous valve in the contralateral jugular vein. Each valve was positioned over a stainless-steel cylinder that had been implanted into the jugular veins in such a manner that there existed no blood-cylinder interaction. Patency of the valves was determined by X-ray venography at 24, 48, and 72 h and at 5 and 8 days postoperatively. All of the umbilical vein venous valves were occluded by the end of 48 h, whereas two of the Pellethane venous valves remained patent for at least 5 days but were occluded at 8 days. The results of this study suggest the possibility of success of Pellethane valve implants in the venous circulation and indicate future directions for study.

摘要

血栓性静脉炎的病理主要源于下肢静脉瓣膜的闭塞。本研究的目的是开发一种可植入人体股静脉系统的人工静脉瓣膜,以改善血栓性静脉炎的有害影响。人工静脉瓣膜由两种材料制成:聚醚酯瓣膜通过浸铸工艺制造;脐静脉瓣膜通过固定工艺制造。这些瓣膜作为植入物在10只实验犬的颈外静脉中进行评估。每只动物在一侧颈外静脉植入一个聚醚酯瓣膜,在对侧颈静脉植入一个脐静脉瓣膜。每个瓣膜放置在一个已植入颈静脉的不锈钢圆柱体上,放置方式使得不存在血液与圆柱体的相互作用。通过术后24、48和72小时以及5天和8天的X线静脉造影来确定瓣膜的通畅情况。所有脐静脉瓣膜在48小时结束时均闭塞,而两个聚醚酯静脉瓣膜至少在5天内保持通畅,但在8天时闭塞。本研究结果表明聚醚酯瓣膜植入静脉循环成功的可能性,并指出了未来的研究方向。

相似文献

1
Development of a prosthetic venous valve.人工静脉瓣膜的研发。
J Biomed Mater Res. 1985 Sep;19(7):827-32. doi: 10.1002/jbm.820190708.
2
Experimental prosthetic vein valve.实验性人工静脉瓣膜
Int Angiol. 1989 Jan-Mar;8(1):7-9.
3
Second-generation percutaneous bioprosthetic valve: a short-term study in sheep.第二代经皮生物瓣膜:在绵羊身上的短期研究。
J Vasc Surg. 2004 Dec;40(6):1223-7. doi: 10.1016/j.jvs.2004.08.027.
4
Percutaneous autologous venous valve transplantation: short-term feasibility study in an ovine model.经皮自体静脉瓣膜移植:在绵羊模型中的短期可行性研究。
J Vasc Surg. 2007 Aug;46(2):338-45. doi: 10.1016/j.jvs.2007.04.060.
5
Significance of spatial orientation of percutaneously placed bioprosthetic venous valves in an ovine model.经皮放置生物人工静脉瓣膜在绵羊模型中的空间定向意义
J Vasc Interv Radiol. 2005 Nov;16(11):1511-6. doi: 10.1097/01.RVI.0000178251.74190.7D.
6
[Morphologic and hydrodynamic characteristics of bovine jugular venous conduit with valves].[带瓣膜牛颈静脉导管的形态学和流体动力学特征]
Hunan Yi Ke Da Xue Xue Bao. 2003 Jun;28(3):298-300.
7
Early experimental experience with a surgically created, totally autogenous venous valve: a preliminary report.关于手术制造的完全自体静脉瓣膜的早期实验经验:初步报告。
J Vasc Surg. 1988 May;7(5):642-6.
8
Is percutaneous implantation of a bovine venous valve in the inferior vena cava a reliable technique to treat chronic venous insufficiency syndrome?经皮将牛静脉瓣膜植入下腔静脉治疗慢性静脉功能不全综合征是一项可靠的技术吗?
Med Sci Monit. 2004 Mar;10(3):BR61-6. Epub 2004 Mar 1.
9
Hemodynamic evaluation of a bioprosthetic venous prosthesis.生物人工静脉假体的血流动力学评估
J Vasc Surg. 1993 Oct;18(4):577-84; discussion 584-6. doi: 10.1067/mva.1993.49081.
10
Tissue-engineered bioprosthetic venous valve: a long-term study in sheep.组织工程生物人工静脉瓣膜:在绵羊身上的长期研究。
Eur J Vasc Endovasc Surg. 2003 Apr;25(4):305-12. doi: 10.1053/ejvs.2002.1873.

引用本文的文献

1
Advances in the diagnosis and treatment of primary deep venous valve insufficiency.原发性下肢深静脉瓣膜功能不全的诊断与治疗进展
Eur J Med Res. 2025 May 23;30(1):409. doi: 10.1186/s40001-025-02589-1.
2
Biohybrid elastin-like venous valve with potential for tissue engineering.具有组织工程潜力的生物杂交弹性蛋白样静脉瓣膜。
Front Bioeng Biotechnol. 2022 Sep 21;10:988533. doi: 10.3389/fbioe.2022.988533. eCollection 2022.
3
Antigen removal process preserves function of small diameter venous valved conduits, whereas SDS-decellularization results in significant valvular insufficiency.
抗原去除过程可保持小直径静脉带瓣管道的功能,而 SDS 去细胞化则导致明显的瓣膜功能不全。
Acta Biomater. 2020 Apr 15;107:115-128. doi: 10.1016/j.actbio.2020.03.003. Epub 2020 Mar 7.